Compensatory Interplay Between Clarin‐1 and Clarin‐2 Deafness‐Associated Proteins Governs Phenotypic Variability in Hearing
Advanced Science · 2026
DOI: 10.1002/advs.202521853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Maureen Wentling und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Institut De L'audition, AP-HP, INSERM U1335, CNRS, Fondation Pour l'Audition, IHU reConnect, Progressive Sensory Disorders, Pathoph…. Hauptthemen laut MEDLINE: Membrane Proteins, Usher Syndromes, Hearing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche under the France 2030 Program, EuroNanoMed-NanoEar, ANR-HearInNoise.
Abstract (Originalsprache)
Usher syndrome type III (USH3) is a genetic disorder characterized by progressive, post‐lingual hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa. USH3 is caused by mutations in CLRN1 , which encodes clarin‐1, a tetraspanin‐like protein. Mutations in CLRN2 , which encodes the related protein clarin‐2, are also implicated in progressive, non‐syndromic hearing loss in both humans and mice. USH3 patients show considerable phenotypic variability, even among individuals with the same mutation. This variability may result from environmental factors or interactions with other inner ear genes, such as CLRN2 . To investigate the functional interplay of these genes, we generated Clrn1 – /− Clrn2 −/− double knockout mice. RNA‐sequencing and functional/physiological analyses revealed that clarin‐1 and clarin‐2 jointly regulate mechanoelectrical transduction, ionic homeostasis, and synaptic organization. Their combined loss leads to more severe hearing phenotype compared to Clrn1 −/− and Clrn2 −/− mice, which reveals a functional compensation between them. CLRN2 variants may exacerbate hearing loss in USH3 patients, supporting inclusion of CLRN2 in genetic screening. By revealing a functional, compensatory interplay between clarin‐1 and clarin‐2, this study reframes CLRN1‐ associated deafness as a network‐dependent disorder and provides a mechanistic basis for genetic stratification and therapeutic directions in USH3 and related sensorineural hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Pasteur, Institut De L'audition, AP-HP, INSERM U1335, CNRS, Fondation Pour l'Audition, IHU reConnect, Progressive Sensory Disorders, Pathophysiology and Therapy, Université Paris Cité, Paris, France.
- Collège Doctoral ED515, Sorbonne Université, Paris, France.
- Collège Doctoral ED158, Sorbonne Université, Paris, France.
- Cellular and Tissular Biology, GIGA-Neurosciences, University of Liège, Liège, Belgium.
- Laboratoire De Neurophysiologie de La Synapse Auditive, Institut De L'audition and Université de Bordeaux, Bordeaux, France.
- Institut Pasteur, Institut De L'audition, AP-HP, INSERM, CNRS, Fondation Pour l'Audition, IHU reConnect, Auditory Therapies Innovation Laboratory, Université Paris Cité, Paris, France.
ORCID-Profile: Sedigheh Delmaghani
Förderung
- Agence Nationale de la Recherche under the France 2030 Program
- EuroNanoMed-NanoEar
- ANR-HearInNoise
- Fondation Recherche Médicale, Association Française contre les Myopathies
- Fondation pour l'Audition
- European-Union's-Horizon 2020 Marie Sklodowska-Curie
- Foundation Fighting Blindness
Zitieren
APA
Wentling, M., Yakhlef Sanchez, A., Thelen, N., Senarisoy, M., Hogg, M., Condamine, S., Lelli, A., Wysocka, E., Patni, P., Vitry, S., Yildizhan, K. Y., Le Gal, S., Nouaille, S., Bowl, M. R., Thiry, M., Dulon, D., Delmaghani, S., & El-Amraoui, A. (2026). Compensatory Interplay Between Clarin‐1 and Clarin‐2 Deafness‐Associated Proteins Governs Phenotypic Variability in Hearing. Advanced Science. https://doi.org/10.1002/advs.202521853
Vancouver
Wentling M, Yakhlef Sanchez A, Thelen N, Senarisoy M, Hogg M, Condamine S, et al. Compensatory Interplay Between Clarin‐1 and Clarin‐2 Deafness‐Associated Proteins Governs Phenotypic Variability in Hearing. Advanced Science. 2026. doi:10.1002/advs.202521853
BibTeX
@article{Wentling2026,
author = {Wentling, Maureen and Yakhlef Sanchez, Aïda and Thelen, Nicolas and Senarisoy, Müge and Hogg, Maria and Condamine, Steven and Lelli, Andrea and Wysocka, Emilia and Patni, Pranav and Vitry, Sandrine and Yildizhan, Kerem Yasin and Le Gal, Sébastien and Nouaille, Sylvie and Bowl, Michael R and Thiry, Marc and Dulon, Didier and Delmaghani, Sedigheh and El-Amraoui, Aziz},
title = {Compensatory Interplay Between Clarin‐1 and Clarin‐2 Deafness‐Associated Proteins Governs Phenotypic Variability in Hearing},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202521853}
}
EUVIMED